Multicentric and multifocal versus unifocal breast cancer: Is the tumor-node-metastasis classification justified?

Breast Cancer Research and Treatment

Volumn 122, Issue 1, 2010, Pages 27-34

  Weissenbacher, Tobias M ^a   Zschage, Madeleine ^a   Janni, Wolfgang ^c   Jeschke, Udo ^a   Dimpfl, Thomas ^b   Mayr, Doris ^d   Rack, Brigitte ^a   Schindlbeck, Christian ^a   Friese, Klaus ^a   Dian, Darius ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b KLINIKUM KASSEL   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Breast cancer; Multicentric; Multifocal; Overall survival; Prognosis; Prognostic factor

Indexed keywords

AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; FLUOROURACIL; HORMONE RECEPTOR; METHOTREXATE; TAMOXIFEN;

ADULT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; COBALT TELETHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; FOLLOW UP; KAPLAN MEIER METHOD; MENOPAUSE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASMS, MULTIPLE PRIMARY; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SECONDARY; STANDARDS; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR BURDEN; KAPLAN-MEIER ESTIMATE;

EID: 77953534410     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0917-9     Document Type: Review

References (32)

1. JR Benson DL Weaver I Mittra M Hayashi 2003 The TNM staging system and breast cancer Lancet Oncol 4 1 56 60 10.1016/S1470-2045(03)00961-6 12517540 (Pubitemid 36124191)
2. G Cserni J Kulka 2003 New TNM classification of breast tumors Orv Hetil 144 32 1563 1568 12974180
3. PF Escobar RJ Patrick LA Rybicki DE Weng JP Crowe 2007 The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups Ann Surg Oncol 14 1 143 147 10.1245/s10434-006-9147-0 17058125 (Pubitemid 44954281)
4. U Veronesi G Viale N Rotmensz A Goldhirsch TNM Rethinking 2006 breast cancer TNM classification for treatment decision-making and research Breast 15 1 3 8 10.1016/j.breast.2005.11.011 16473737 (Pubitemid 43210543)
5. NJ Bundred 2001 Prognostic and predictive factors in breast cancer Cancer Treat Rev 27 3 137 142 10.1053/ctrv.2000.0207 1:STN:280:DC%2BD3Mzls1Wnuw%3D%3D 11417963 (Pubitemid 32452013)
6. TS Dabakuyo F Bonnetain P Roignot ML Poillot G Chaplain T Altwegg G Hedelin P Arveux 2008 Population-based study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival Ann Oncol 19 2 276 283 10.1093/annonc/mdm491 1:STN:280:DC%2BD1c%2FotlemsQ%3D%3D 17962200 (Pubitemid 351201708)
7. M Younes M Lane CC Miller R Laucirica 1997 Stratified multivariate analysis of prognostic markers in breast cancer a: preliminary report Anticancer Res 17 2B 1383 1390 1:STN:280:DyaK2s3otleksg%3D%3D 9137503
8. N Duraker ZC Caynak 2005 Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes Cancer 104 4 700 707 10.1002/cncr.21199 16003773 (Pubitemid 41113668)
9. A Garcia-Vilanova Comas A Garcia Vilanova E Fuster-Diana N Martinez-Alzamora J Fernandez-Tena J Garcia-Vilanova Comas M Garcia-Vilanova Comas 2006 Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study Clin Transl Oncol 8 2 108 118 10.1007/s12094-006-0167-9 1:STN:280:DC%2BD283itlamtw%3D%3D 16632425
10. LS Wanami HY Chen S Peiro A Garcia de Herreros RE Bachelder 2008 Vascular endothelial growth factor-A stimulates snail expression in breast tumor cells: Implications for tumor progression Exp Cell Res 314 13 2448 2453 10.1016/j.yexcr.2008.05.004 1:CAS:528:DC%2BD1cXptVekurk%3D 18554584
11. J Wang RO Barnes NR West M Olson JE Chu PH Watson 2008 Jab1 is a target of EGFR signaling in ER-alpha negative breast cancer Breast Cancer Res 10 3 R51 10.1186/bcr2105 18534028
12. Y Yildirim N Gunel U Coskun B Sancak N Bukan S Aslan A Cetin 2008 Serum big endothelin-1 levels in female patients with breast cancer Int Immunopharmacol 8 8 1119 1123 10.1016/j.intimp.2008.03.023 1:CAS:528: DC%2BD1cXnt1art7k%3D 18550016
13. LH Sobin P Hermanek RV Hutter 1988 TNM classification of malignant tumors. A comparison between the new (1987) and the old editions Cancer 61 11 2310 2314 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0. CO;2-X 1:STN:280:DyaL1c3htVajtQ%3D%3D 3284634
14. U Altmann V Haeberlin A Tafazzoli J Dudeck 1997 Application of a standard methodology for the development of messages and aspects of realization in the area of tumour documentation Stud Health Technol Inf 43 Pt B 776 780 1:STN:280:DyaK1c3mt1WktQ%3D%3D
15. BA Gusterson 2003 The new TNM classification and micrometastases Breast 12 6 387 390 10.1016/S0960-9776(03)00141-3 1:STN:280:DC%2BD3srnvV2htA%3D%3D 14659110 (Pubitemid 38008648)
16. A Johnson 2006 TNM classification Veronesi et al Breast 15 5 580 10.1016/j.breast.2006.06.002 16876412 (Pubitemid 44509781)
17. Savran VR, Fetsych TH, Savran VV, Tril OV, Myshakivs'kyi OM (2006) Stages of breast cancer. Lik Sprava 3:11-17
18. SE Singletary FL Greene 2003 Revision of breast cancer staging: the 6th edition of the TNM classification Semin Surg Oncol 21 1 53 59 10.1002/ssu.10021 12923916 (Pubitemid 37127474)
19. O Gentilini E Botteri N Rotmensz L Da Lima M Caliskan CA Garcia-Etienne I Sosnovskikh M Intra G Mazzarol S Musmeci, et al. 2009 Conservative surgery in patients with multifocal/multicentric breast cancer Breast Cancer Res Treat 113 3 577 583 10.1007/s10549-008-9959-7 18330695
20. O Gentilini P Veronesi G Gatti M Intra G Mazzarol G Trifiro F Bassi M Caliskan L Da Lima V Galimberti, et al. 2007 Conservative approach for breast cancer. The experience of the European Institute of Oncology Minerva Chir 62 6 447 458 1:STN:280:DC%2BD1c7jvVGgtA%3D%3D 18091655
21. C Spinelli P Berti E Ricci P Miccoli 1992 Multicentric breast tumour: an anatomical-clinical study of 100 cases Eur J Surg Oncol 18 1 23 26 1:STN:280:DyaK387ks1Grtg%3D%3D 1737589
22. T Wakabayashi SI Tsuchiya G Asano 1995 Unilateral multicentric breast carcinoma studied by whole mammary gland serial sectioning Breast Cancer 2 2 91 98 10.1007/BF02966946 11091538
23. B Fowble IT Yeh DJ Schultz LJ Solin EF Rosato L Jardines J Hoffman B Eisenberg MC Weiss G Hanks 1993 The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microclassifications Int J Radiat Oncol Biol Phys 27 3 567 573 1:STN:280:DyaK2c%2Fkt1aqsw%3D%3D 8226150
24. AA Andea D Bouwman T Wallis DW Visscher 2004 Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma Cancer 100 1 20 27 10.1002/cncr.11880 14692020 (Pubitemid 37553535)
25. AA Andea T Wallis LA Newman D Bouwman J Dey DW Visscher 2002 Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma Cancer 94 5 1383 1390 10.1002/cncr.10331 11920492 (Pubitemid 34212630)
26. LH Sobin FL Greene 2003 Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma Cancer 97 5 1364 10.1002/cncr.11182 12599247 (author reply 1365) (Pubitemid 36237326)
27. LH Sobin FL Greene 2004 Multifocal/multicentric breast carcinoma Cancer 100 11 2488 2489 10.1002/cncr.20286 15160362 (author reply 2489) (Pubitemid 38657903)
28. G Vlastos IT Rubio NQ Mirza LA Newman R Aurora J Alderfer AU Buzdar SE Singletary 2000 Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer Ann Surg Oncol 7 8 581 587 1:STN:280: DC%2BD3cvltVGksA%3D%3D 11005556
29. NJ Coombs J Boyages 2005 Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 23 30 7497 7502 10.1200/JCO.2005.02.1147 16234516
30. J Fajdic D Bukovic D Gugic M Habek I Hojsak N Bukovic I Herman T Stanceric 2003 Unilateral multicentric breast cancer Coll Antropol 27 2 693 698 14746160
31. JL Oh MJ Dryden WA Woodward TK Yu W Tereffe EA Strom GH Perkins L Middleton KK Hunt SH Giordano, et al. 2006 Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy J Clin Oncol 24 31 4971 4975 10.1200/JCO.2006.07.6067 17075114 (Pubitemid 46631398)
32. O Anastassiades E Iakovou N Stavridou J Gogas A Karameris 1993 Multicentricity in breast cancer. A study of 366 cases Am J Clin Pathol 99 3 238 243 1:STN:280:DyaK3s7ptV2gug%3D%3D 8447284